Published in Law and Health Weekly, January 14th, 2006
This agreement is one of the largest service contracts to date for BioFocus.
Under the terms of the extended agreement, Galapagos' service division BioFocus will continue to provide Amgen with drug-discovery expertise for multiple ion channel targets, including assay development, high-throughput screening, chemistry, and molecular informatics. In return,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.